IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection

Imanis Life Sciences


Latest News

Stay up to date on the latest....

FDA: New COVID-19 Variants May Cause False Negatives on Diagnostic Tests

January 15, 2021

On January 8, the Food and Drug Administration (FDA) warned of the potential for coronavirus tests to produce false negative results because of genetic variants of the SARS-CoV-2 virus. This announcement comes after a new COVID-19 strain called B.1.1.7 emerged in the United Kingdom, which has also been detected in the United States.

Continue Reading

The 20 Hottest Digital Health Startups From Flyover Country, 2021

January 13, 2021

The Observer, in advance of the JP Morgan Healthcare Conference, names Imanis Life Sciences and sister company Vyriad as one of the hottest health startups from flyover country of 2021.

Continue Reading

Inspirational Women in STEM and Tech: Dr. Rianna Vandergaast of Imanis Life Sciences On The 5 Leadership Lessons She Learned From Her Experience

January 10, 2021

Imanis Life Sciences Principal Scientist, Rianna Vandergaast, Ph.D talks to Authority Magazine about lessons learned about leadership and the principles that guide her in the world of STEM.

Continue Reading

Heroes of the COVID Crisis: How Stephen Russel & Imanis Life Sciences Stepped Up to Make a Difference During the Pandemic

December 23, 2020

Imanis Life Sciences CEO and co-founder, Dr. Stephen Russell, talks to Authority Magazine about Heroes – what makes a hero, heroes in his own life, and heroes amid the current world climate.

Continue Reading

If You’ve Already Had COVID-19, Do You Need the Vaccine? Here’s What Experts Say

December 17, 2020

As the long-awaited COVID-19 vaccine distribution process begins in the United States, there’s plenty of deliberation around who gets the vaccine, and when. Much attention has been brought to the people who have already been infected with COVID-19. Should they also get the vaccine? Don’t people who have had COVID-19 have immunity?

Continue Reading

New COVID-19 antibody test developed in Rochester

December 9, 2020

While many wait for news of a COVID-19 vaccine in the United States, a Rochester company says it has created something that can help figure out if you can fight the virus off on your own.

Continue Reading

Antibody test puts Rochester at forefront of tracking COVID-19 immunity

How immune are you? That’s the question developers of a new COVID-19 antibody test or assay hope to answer for patients and doctors.

Continue Reading

New test by Minnesota biotech firm can read COVID antibody levels

December 7, 2020

So, what’s your titer? That question, still strange sounding, may soon become important as vaccines bring about the endgame for COVID-19.

Continue Reading

Imanis Life Sciences Announces Improvements and Increased Capacity of IMMUNO-COVTM, a First-in-Class Neutralizing Antibody Test for COVID-19

November 19, 2020

High-throughput clinical assay detects and quantifies SARS-CoV-2 neutralizing antibodies

Continue Reading

Dueling quantitative COVID-19 neutralizing antibody tests roll out as vaccines approach completion

As COVID-19 vaccines ready themselves for market, two companies have turned their attention to what comes next – verifying whether the vaccines provide effective and lasting protection against SARS-CoV-2.

Continue Reading

Study suggests herd immunity to COVID-19 in New York City is low

November 9, 2020

Researchers in the United States have estimated that the proportion of people in New York City who developed antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave of the coronavirus disease 2019 (COVID-19) pandemic is around one in eight.

Continue Reading

Transforming the treatment of cancer with oncolytic viruses

October 4, 2020

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Stephen Russell, CEO of Vyriad. Dr. Russell reveals invaluable insights for those looking for or currently putting together partnership deals.

Continue Reading

Imanis Life Sciences to Present IMMUNO-COV, a First-in-Class Neutralizing Antibody Test for COVID-19, at American Society of Gene and Cell Therapy Symposium

September 14, 2020

Imanis Life Sciences, LLC announced today upcoming presentations about the development and validation of IMMUNO-COV™, the first scalable, quantitative neutralizing antibody test for COVID-19.

Continue Reading

Heroes of the Pandemic

August 28, 2020

Six months now into this perplexing and powerful pandemic, we’ve grown accustomed to seeing our “front line” heroes whenever we venture out and also when we don’t.

Continue Reading

Mayo Clinic to Offer Vyriad Neutralizing Antibody Test

June 11, 2020

Mayo Clinic has licensed the Vyriad IMMUNO-COV™ antibody test that detects and quantifies neutralizing antibodies, the critical subset of antibodies known to protect against SARS-CoV-2 viral infections.

Continue Reading

Scientific Paper Available on Development and Validation of IMMUNO-COV™, Vyriad’s SARS-CoV-2 Virus-Neutralizing Antibody Test

May 28, 2020

Vyriad and Imanis Life Sciences announced today the publication of a scientific paper on the development and validation of IMMUNO-COV™, a high-throughput clinical test to quantitatively measure SARS-CoV-2-neutralizing antibodies, the specific subset of anti-SARS-CoV-2 antibodies that block viral infection.

Continue Reading

Development and Validation of IMMUNO-COV™: a test measuring SARS-CoV-2-neutralizing antibodies

Imanis Life Sciences and Vyriad announced today the publication of a scientific paper on the development and validation of IMMUNO-COV™, a high-throughput clinical test to quantitatively measure SARS-CoV-2-neutralizing antibodies, the specific subset of anti-SARS-CoV-2 antibodies that block viral infection. The paper is available on bioRxiv, a free online archive and distribution service for non-peer-reviewed manuscripts […]

Continue Reading

Vyriad Inc. Announces Development of a New Antibody Test to Determine Protective Immunity From COVID-19

May 12, 2020

Vyriad, Inc. announced today that it has completed the development of a serology test to measure protective immunity against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Continue Reading

Imanis Life Sciences Presenting at the 2019 ASGCT Annual Meeting

April 18, 2019

Imanis Life Sciences will be exhibiting at the 2019 ASGCT annual meeting in Washington, DC, from Monday, April 29 through Wednesday, May 1. In addition, Rianna Vandergaast, Ph.D., a Senior Scientist at Imanis, will present during the Tools and Technologies Forum on Monday, April 29, 2019 at 4:15 PM ET. The presentation will highlight Imanis’ NIS […]

Continue Reading

Imanis moves to new laboratory space

February 12, 2019

On January 21, Imanis Life Sciences moved to a new laboratory space in the Rochester Technology Campus. The new 25,000-square foot facility features molecular biology labs, several tissue culture spaces, as well as lab space designated for the performance of correlative testing for oncolytic virus clinical trials. Despite record low temperatures, the ribbon cutting ceremony […]

Continue Reading

Learning Resources

Stay Informed

Stay up to date on the latest from the Imanis team, including product releases, promotional codes, and exciting new advancements in noninvasive in vivo imaging!